Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Avenue Therapeutics Inc (ATXI)

NASDAQ
Currency in USD
Disclaimer
0.147
-0.005(-3.34%)
Closed
After Hours
0.1470.000(-0.204%)

ATXI Price Commentary

Avenue Therapeutics, a New York-based biotechnology company, announced on January 12, 2024 that it plans to increase its workforce by 300% by the end of April 2024. The company is hiring to work on a number of new projects , including: A new treatment for lung cancer Avenue Therapeutics is developing a new treatment for lung cancer that uses a combination of immunotherapy and chemotherapy. The treatment is designed to attack cancer cells more effectively and reduce the side effects of chemotherapy. A new treatment for Alzheimer's disease Avenue Therapeutics is developing a new treatment for Alzheimer's disease that uses a combination of drugs and gene therapy. The treatment is designed to reduce the buildup of amyloid plaques in the brain, which is believed to be one of the causes of the disease. A new treatment for cystic fibrosis Avenue Therapeutics is developing a new treatment for cystic fibrosis that uses a combination of gene therapy and cell therapy. Treatment is designed to correct the genetic defect that causes the disease. These projects are unique in the world for their innovative approach to the treatment of serious diseases. If successful, they could have a significant impact on the health of patients around the world. In addition to these projects, Avenue Therapeutics is also developing new treatments for other diseases, such as multiple sclerosis, rheumatoid arthritis and diabetes. The company is committed to researching new therapies that can improve patients' lives.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.